L-Glutathione is naturally produced in the body, primarily in the liver, but certain factors like poor diet, pollution, and aging can lead to reduced levels
In experimental models, OLETF rats have shown local RAS activation, which resulted in oxidative stress and kidney progressive damage, whereas treatment with dapagliflozin remarkably lowered the urinary ANG II and AGT levels (36)
Research suggests GLP-1 receptors may be present in taste buds and throughout the gastrointestinal tract, though this evidence is primarily from preclinical studies
Curr Cardiol Rep
Yuan Z, Li D, Feng P, Xue G, Ji C, Li G et al (2017) A novel GLP-1/GIP dual agonist is more effective than liraglutide in reducing inflammation and enhancing GDNF release in the MPTP mouse model of Parkinsons disease
There is no reason that anyone with a history of thyroid cancer other than medullary thyroid cancer should have any question about the safety of GLP-1 [treatments]